Insmed, Agios rise; DraftKings, Atlantica fall, Tuesday, 5/28/2024
Stocks that traded heavily or had substantial price changes on Tuesday: Insmed, Agios rise; DraftKings, Atlantica fall
NEW YORK — Stocks that traded heavily or had substantial price changes on Tuesday:
United States Cellular Corp., up $5.24 to $48.22.
T-Mobile is buying the telecommunications company's wireless operations and some spectrum assets in a deal valued at $4.4 billion.
Energy Transfer LP, up 5 cents to $15.49.
The natural gas pipeline services company is buying WTG Midstream.
Insmed Inc., up $26.06 to $48.06.
The biopharmaceutical company said a potential lung disease treatment met a key goal in a pivotal study.
Agios Pharmaceuticals Inc., up $7.31 to $38.81.
The biopharmaceutical company will sell rights to its 15% royalty on a potential brain cancer drug for $905 million.
Corcept Therapeutics Inc., up $4.09 to $31.61.
The drug developer said its potential Cushing syndrome treatment met a key study goal and it expects to apply for U.S. approval in the third quarter.
DraftKings Inc., down $4.20 to $36.61.
The online sports betting company reportedly faces higher taxes in Illinois following a budget action in the state senate.
Atlantica Sustainable Infrastructure Plc., down $1.21 to $22.21.
Energy Capital Partners is buying the owner of electric power assets.
Freeport-McMoRan Inc., up $2.10 to $53.63.
The copper miner gained ground along with prices for the base metal.
24/7 coverage of breaking news and live events
Read more on abcnews.go.com
